CVS HEALTH Corp — Director's Dealing 2021

Apr 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-03-31

Reporting Person: Clark James David (SVP, Cont & Chief Acct Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-31	Common Stock	M	5350	$74.29	Acquired	12594.2554	Direct
2021-03-31	Common Stock	S	5350	$76.00	Disposed	7244.2554	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-31	Stock Option	$74.29	M	5350	Disposed	2021-04-01	Common Stock (5350)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (restricted)	16648	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$102.26	2022-04-01	Common Stock (6059)	6059	Direct
Stock Option	$104.82	2023-04-01	Common Stock (7044)	7044	Direct
Stock Option	$78.05	2024-04-03	Common Stock (9050)	9050	Direct
Stock Option	$62.21	2025-04-01	Common Stock (7513)	7513	Direct
Stock Option	$54.19	2029-04-01	Common Stock (24240)	24240	Direct
Stock Option	$58.34	2030-04-01	Common Stock (17157)	17157	Direct

Footnotes

F1: All sales were effective pursuant to a Rule 10b5-1 plan.

F2: Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.

F3: Options became exercisable in four equal annual installments beginning on 4/1/2016.

F4: Options became exercisable in four equal annual installments beginning on 4/1/2017.

F5: Options became exercisable in four equal annual installments beginning on 4/3/2018.

F6: Options became exercisable in four equal annual installments, commencing 4/1/2019.

F7: Options became exercisable in four equal annual installments, commencing 4/1/2020.

F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.